CAITLIN CLARKIN: Open Payments
NPI 1174001614 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,531 in 36 payments from 19 companies in 2025. Trend: 2023 $329 · 2024 $649 · 2025 $1,531
Food & beverage: $1,432Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $181 |
| JAZZ PHARMACEUTICALS INC. | 3 | $151 |
| Kite Pharma, Inc. | 2 | $140 |
| ADC THERAPEUTICS AMERICA, INC. | 2 | $139 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 5 | $118 |
| BeOne Medicines USA, Inc. | 1 | $114 |
| Daiichi Sankyo Inc. | 4 | $106 |
| Geron Corporation | 1 | $106 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
Products named: ZIIHERA, ZYNLONTA, LIBTAYO, TEVIMBRA, RYTELO, JAKAFI, Enhertu, Doptelet.
Industry payments across NV — which companies pay providers there.
